Surgical Robots Market 2019 with Top 20 Countries data with Top Players Surgical, Think Surgical, TranEnterix, Zimmer Biomet, Stryker, Smith & Nephew, and Medrobotics

Surgical robots consists of a camera arm and mechanical arms with surgical instruments, which are controlled by surgeons on computer console that offers high definition and magnified 3-D view of the surgical site. Surgical robots aids in performing various complex surgical procedures with more flexibility, precision, and control than conventional surgical procedures.

Surgical robots are primarily preferred in minimally invasive surgery procedures, which are performed through tiny or small incisions. Moreover, the use of surgical robots enables surgeons to perform delicate and complex procedures, which could be difficult or impossible through other methods. Problems associated with robotic-assisted surgery are similar to that of open surgery, which includes high risk of infection, bleeding, and cardiopulmonary risks of anesthesia. Furthermore, robotic surgery could led to death of the patient, owing to human errors in operating the technology and risks of mechanical failure. This could hamper growth of the surgical robots market.

The global surgical robots market is estimated to be valued at US$ 3,380.3 million in 2017 and is expected to witness a robust CAGR of 13.4% over the forecast period (2017–2025).

The Global Surgical Robots Market by Product Type (Instruments & Accessories, and Robotic Systems (Da Vinci Surgical, ROSA, MAKO RIO, ROBODOC, and Others)), by Surgery Type (Gynecology Surgery, General Surgery, Urology Surgery, Cardiovascular Surgery, Neurosurgery, Orthopedic Surgery, and Other Surgery), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) is estimated US$ 3,380.3 million in 2017 and is projected to exhibit a CAGR of 13.4% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. The robotic technique are helpful due to smaller incisions, which lead to lower morbidity, less postoperative pain, and shorter hospital stays, that is similar to minimally invasive surgery. According to the data published in Frontiers in Surgery Journal in 2016, over 3,200 robotic platforms have been installed worldwide and approximately 570,000 da Vinci procedures were performed in 2014.

Request A Sample Copy:
https://www.coherentmarketinsights.com/insight/request-sample/496

Key players in the surgical robots market are focused on acquisition and new product launches in order to enhance their market share. For instance, Stryker acquired Mako Surgical Robotic Systems for US$ 1.65 Bn in 2013 and in 2016, it launched Mako surgical robots for total knee replacement. Furthermore, in 2015, TransEnterix acquired SOFAR Surgical Robotics unit for US$ 100 Mn. In 2016, Zimmer Biomet Holding Inc. acquired surgical robotics provider, Medtech SA, for US$ 132 Mn to increase its portfolio and in 2016, MEDTECH received clearance from the U.S. Food and Drug Administration (FDA) to market the ROSA Spine robot in the U.S. Furthermore, in 2013, Auris Surgical Robotics acquired Hassen Medical, as the Hassen Medical specialized in intravascular robotic catheter systems. In 2016, the FDA granted 510(k) clearance to the Ares robot-assisted bronchoscopy platform developed by stealthy Auris Surgical Robotics

In 2015, Smith & Nephew — a British-based orthopedics giant — expanded its foothold in the surgical robotics market by acquiring Blue Belt Technologies and its Navio robotics system, which is a U.S.-based company.

Increasing US Food and Drug Administration approval for surgical robots is also expected to favor growth of surgical robots market. For instance, in October 2017, US Food and Drug Administration (FDA) approved the Senhance system, of TransEnterix, which is a robotically assisted surgical device for minimally invasive surgeries. In 2016, U.S. FDA approved the first medical robot from Auris Surgical — a startup led by the co-founder of Intuitive Surgical — a developer of Da Vinci robots.

Furthermore, Stryker received FDA approval in August 2015, however, delayed its worldwide sales until 2017, and so MAKO RIO was used only in 65 hospitals in the U.S., the U.K., Australia, and Germany from 2015 –2017. In 2014, ROBODOC Encore Surgical System received 510(k) clearance from the US Food and Drug Administration (FDA) for total hip Arthroplasty procedures.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/496

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.